Qinying Zhao

发表

Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database

Kaori Ito, B. Corrigan, Qinying Zhao, 2011, Alzheimer's & Dementia.

Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study

A. Sié, Qinying Zhao, B. Ogutu, 2015, Malaria Journal.

Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease: A Phase I, Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Study

Qinying Zhao, M. Borrie, K. Bales, 2013, Clinical neuropharmacology.

Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease

Qinying Zhao, M. Bednar, A. Burstein, 2013, Clinical neuropharmacology.

Bioequivalence of Omeprazole Delayed-Release Capsules in HealthyFilipino Subjects

Qinying Zhao, A. Płotka, B. Damle, 2014 .

Bioequivalence and Bioavailability of an Orodispersible Tablet of Sildenafil Citrate in Healthy Chinese Male Subjects

Qinying Zhao, Y. Lv, R. Labadie, 2020, Clinical pharmacology in drug development.

Clinical Characteristics of Patients With HNF1-alpha MODY: A Literature Review and Retrospective Chart Review

Qinying Zhao, Ming Liu, Min Wang, 2022, Frontiers in Endocrinology.

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy

C. Jack, K. Kantarci, Qinying Zhao, 2017, Alzheimer's & dementia.

Pharmacokinetic and Safety Assessments of Concurrent Administration of Risperidone and Donepezil

Qinying Zhao, X. Jia, L. Pesco‐Koplowitz, 2003, Journal of clinical pharmacology.

Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers

Qinying Zhao, T. Fullerton, A. Burstein, 2011, Journal of clinical pharmacology.

Pharmacokinetics and pharmacodynamics of ponezumab (PF-04360365) following a single-dose intravenous infusion in patients with mild to moderate Alzheimer's disease

Qinying Zhao, M. Bednar, A. Burstein, 2010, Alzheimer's & Dementia.

Galantamine Pharmacokinetics, Safety, and Tolerability Profiles Are Similar in Healthy Caucasian and Japanese Subjects

Qinying Zhao, A. Peer, N. Osselaer, 2002, Journal of clinical pharmacology.

Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma

Qinying Zhao, Yi Huang, Mei Zhang, 2022, Frontiers in Genetics.

The link between self-uncertainty and conspicuous consumption: Tolerance of uncertainty as a moderator

Qinying Zhao, Hongjin Zhu, Xiuxin Wang, 2023, Frontiers in Psychology.

Pharmacokinetics of Intravenous Itraconazole followed by Itraconazole Oral Solution in Patients with Human Immunodeficiency Virus Infection

Qinying Zhao, Honghui Zhou, L. Pesco‐Koplowitz, 2001, Journal of clinical pharmacology.

Influence of Coadministration of Fluoxetine on Cisapride Pharmacokinetics and QTc Intervals in Healthy Volunteers

Qinying Zhao, L. Pesco‐Koplowitz, Q. Zhao, 2001, Pharmacotherapy.

Surgical Resection of Pancreatic Hepatoid Carcinoma Followed by Combined Transarterial Chemoembolization and Immunotherapy: A Case Report

Qinying Zhao, Qiang Liu, Xiong Yan, 2021, OncoTargets and therapy.

OTT_A_323811 4575..4578

Qinying Zhao, Xiong Yan, Qian Liu, 2021 .

U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors

P. Jänne, Qinying Zhao, H. Wakelee, 2020, Clinical Cancer Research.

Rationale for Combination Therapy With Galantamine and Memantine in Alzheimer's Disease

Qinying Zhao, K. Edwards, G. Grossberg, 2006, Journal of clinical pharmacology.

Meta-Analysis of the Relationship between Abdominal Obesity and Diabetic Kidney Disease in Type 2 Diabetic Patients

Qinying Zhao, Zhihong Wang, X. Yi, 2021, Obesity Facts.

Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets

Qinying Zhao, T. Tensfeldt, D. Mould, 2014, Malaria Journal.

Relative Bioavailability of a Fixed-Combination Tablet Formulation ofAzithromycin and Chloroquine in Healthy Adult Subjects

Ra, Qinying Zhao, R. Labadie, 2013 .

Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa

Qinying Zhao, J. Kimani, R. Rojo, 2016, PloS one.

Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study

A. Sié, Qinying Zhao, B. Ogutu, 2015, Malaria Journal.

Bioequivalence & Bioavailability

Qinying Zhao, R. Labadie, R. Chandra, 2011 .

Steady‐State Pharmacokinetics of Galantamine Are Not Affected by Addition of Memantine in Healthy Subjects

Qinying Zhao, M. Gold, S. Ramael, 2005, Journal of clinical pharmacology.

Optimal Cut-Offs of Body Mass Index and Waist Circumference to Identify Obesity in Chinese Type 2 Diabetic Patients

Qinying Zhao, Qifu Li, Zhihong Wang, 2020, Diabetes, metabolic syndrome and obesity : targets and therapy.

Population Dose-Response Model for ADAS-cog Scores in Patients with Alzheimers Disease by Meta-Analysis of a Mixture of Summary and Individual Data

Brian Corrigan, Jonathan French, Kaori Ito, 2009 .

Pharmacokinetic and Safety Assessments of Galantamine and Risperidone after the Two Drugs Are Administered Alone and Together

Qinying Zhao, K. Lasseter, L. Janssens, 2002, Journal of clinical pharmacology.

Safety and pharmacokinetics following a single 10-minute intravenous infusion of the anti-amyloid mAb ponezumab (PF-04360365) in patients with mild to moderate Alzheimer's disease

Qinying Zhao, M. Bednar, A. Burstein, 2010, Alzheimer's & Dementia.

Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer's disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study.

Qinying Zhao, M. Bednar, T. Ishibashi, 2013, International journal of clinical pharmacology and therapeutics.

Pharmacokinetics and Safety of Galantamine in Subjects with Hepatic Impairment and Healthy Volunteers

Qinying Zhao, T. Verhaeghe, L. Truyen, 2002, Journal of clinical pharmacology.

Early-onset type 2 diabetes

Qinying Zhao, Qifu Li, Zhihong Wang, 2020, Medicine.

Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes

Qinying Zhao, Qifu Li, J. He, 2021, Diabetes.

Qinying Zhao, T. Tensfeldt, D. Mould, 2014, Malaria Journal.

Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers

Qinying Zhao, L. Janssens, T. Verhaeghe, 2005, Current medical research and opinion.

Safety and pharmacokinetics of the anti-amyloid monoclonal antibody PF-04360365 following a single infusion in patients with mild-to-moderate Alzheimer's disease: Preliminary results

Qinying Zhao, M. Bednar, C. Billing, 2009, Alzheimer's & Dementia.

Preliminary population pharmacokinetic modeling of PF-04360365, a humanized anti-amyloid monoclonal antibody, in patients with mild-to-moderate Alzheimer's disease

B. Corrigan, Qinying Zhao, T. Nicholas, 2009, Alzheimer's & Dementia.